Logiscreen

Teva- Pharmaceutical Industries Ltd

$34.19
Market Cap 39.31B
ROE 20.7%
Gross Margin 49.5%
Debt/Equity 2.1
Current Ratio 1.0
Revenue QoQ 2.3%
EPS QoQ 0.7%
F-Score 3

About

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
25.31
vs median 33.61
P/B
4.81
vs median 2.16
ROE
0.21
vs median 0.09

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics